Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
Conditions
- ADHD
- Attention Deficit Hyperactivity Disorder
Interventions
- DRUG: Atomoxetine and OROS Methylphenidate
Sponsor
Massachusetts General Hospital
Collaborators